The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon κ-opioid receptor stimulation in the rat heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 1065-1070

  Bian, Jin Song ^a   Zhang, Wei Min ^a   Pei, Jian Ming ^a   Wong, Tak Ming ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOBUTYL 8 METHOXYMETHYL 1 METHYLXANTHINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 9 (2 HYDROXY 3 NONYL)ADENINE; CILOSTAMIDE; CYCLIC AMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; KAPPA OPIATE RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE; PROTEIN KINASE C; ROLIPRAM; ZAPRINAST;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-3-ISOBUTYLXANTHINE; 3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; MALE; MYOCARDIUM; PHENANTHRIDINES; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; TETRADECANOYLPHORBOL ACETATE;

EID: 0034008672     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Beavo JA and Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150-155.
2. 2+ or protein kinase C in alpha-1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells. Mol Pharmacol 55:296-303.
3. Bian JS, Wang HX, Zhang WM and Wong TM (1998) Effects of κ-opioid receptor stimulation in the heart and the involvement of protein kinase C. Br J Pharmacol 124:600-606.
4. Bode DC and Brunton LL (1988) Post-receptor modulation of the effects of cyclic AMP in isolated cardiac myocytes. Mol Cell Biochem 82:13-18.
5. Boudreau RJ and Drummond GI (1975) A modified assay of 3′;5′-cyclic-AMP phosphodiesterase. Anal Biochem 63:388-399.
6. Buxton IL and Brunton LL (1985) Action of the cardiac alpha 1-adrenergic receptor. Activation of cyclic AMP degradation. J Biol Chem 260:6733-6737.
7. Chulak C, Couture R and Foucart S (1995) Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria. Br J Pharmacol 115:330-334.
8. Dong H, Sheng JZ, Lee CM and Wong TM (1993) Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisopuinoline. Br J Pharmacol 109:113-119.
9. Dubois M, Nemoz G, Lagarde M and Prigent AF (1990) Phospholipid metabolism modulates cyclic nucleotide phosphodiesterase activity in rat heart microsomes. Biochem Biophys Res Commun 170:800-809.
10. Geoffroy V, Fouque F, Nivet V, Clot JP, Lugnier C, Desbuquois B and Benelli C (1999) Activation of a cGMP-stimulated cyclic AMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction. Eur J Biochem 259:892-900.
11. Hichami A, Boichot E, Germain N, Coqueret O and Lagente V (1996) Interactions between cyclic AMP- and cGMP-dependent protein kinase inhibitors and phosphodiesterase IV inhibitors on arachidonate release from human monocytes. Life Sci 59: PL255-PL261.
12. + exchanger isoforms (NHE-1, -2, and -3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways. J Biol Chem 270:29209-29216.
13. Law PY and Loh HH (1993) Delta-Opioid receptor activates cyclic AMP phosphodiesterase activities in neuroblastoma κ glioma NG108-15 hybrid cells. Mol Pharmacol 43:684-693.
14. Le Goas F, Amiel C and Friedlander G (1991) Protein kinase C modulates cAMP content in proximal tubular cells: Role of phosphodiesterase inhibition. Am J Physiol 261:F587-F592.
15. Lerner U, Ransjo M and Fredholm BB (1986) Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro. Biochem Pharmacol 35:4177-4189.
16. Liu SF, Crawley DE, Rohde JA, Evans TW and Barnes PJ (1992) Role of nitric oxide and guanosine 3′,5′-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol 107:861-866.
17. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
18. Martinez E, Penafiel R, Collado MC and Hernandez J (1995) Diazepam potentiates the positive inotropic effect of isoprenaline in rat ventricle strips: role of cyclic AMP. Eur J Pharmacol 282:169-175.
19. Mery PF, Pavoine C, Pecker F and Fischmeister R (1995) Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol Pharmacol 48:121-130.
20. Michael AE and Webley GE (1991) Prostaglandin F2 alpha stimulates cyclic AMP phosphodiesterase via protein kinase C in cultured human granulosa cells. Mol Cell Endocrinol 82:207-214.
21. Murphy MP, Hohl CM, Brierley GP and Altschuld RA (1982) Release of enzymes from adult rat heart myocytes. Circ Res 51:560-568.
22. Nakano H, Kobayashi E, Takahashi I, Tamaoki T, Kuzuu Y and Iba H (1987) Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60. J Antibiot Tokyo 40:706-708.
23. Prigent AF, Nemoz G, Picq M, Dubois M and Pacheco H (1984) Activation of the cyclic nucleotide phosphodiesterase from rat heart cytosol by phospholipase C. Biochem Biophys Res Commun 119:236-244.
24. Reupcke C, Paraschos A, Honbo N and Karliner JS (1993) A phorbol ester augments cyclic AMP content and adenylyl cyclase activity in neonatal rat cardiac myocytes despite reduced beta adrenoceptor density. Cardiovasc Res 27:2179-2185.
25. Schluter KD, Weber M and Piper HM (1995) Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J 310:439-444.
26. Schwartz DD, Williams JL and Malik KU (1993) Contribution of calcium to isoproterenol-stimulated lipolysis in the isolated perfused rabbit heart. Am J Physiol 266:E439-E445.
27. Shahid M and Rodger IW (1989) Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: Role of phosphodiesterase inhibition. Br J Pharmacol 98:291-301.
28. Shimizu E, Kobayashi Y, Oki Y, Kawasaki T, Yoshimi T and Nakamura H (1999) OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells. Life Sci 64:2081-2088.
29. i in myocytes. Am J Physiol 272:C560-C564.
30. Strasser RH, Braun Dullaeus R, Walendzik H and Marquetant R (1992) Alpha 1-receptor-independent activation of protein kinase C in acute myocardial ischemia. Mechanisms for sensitization of the adenylyl cyclase system. Circ Res 70:1304-1312.
31. Tetsuka T, Kusano E, Takeda S, Homma S, Yoshida I, Ando Y and Asano Y (1995) Activation of protein kinase C stimulates cyclic AMP phosphodiesterase in rat renal collecting tubule. Am J Physiol 268:F808-F814.
32. Thompson WJ and Appleman MM (1971) Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10:311-316.
33. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D and Kirilovsky J (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781.
34. Turner NC, Wood LJ, Burns FM, Gueremy T and Souness JE (1993) The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Br J Pharmacol 108:876-883.
35. 2+ in cardiac myocytes. Am J Physiol 261:H1671-H1674.
36. Ventura C and Pintus G (1997) Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster III Autocrine stimulation of prodynorphin gene expression by dynorphin B. J Biol Chem 272:6699-6705.
37. Weishaar RE, Kobylarz Singer DC and Steffen RP (1987) Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Circ Res 61:539-547.
38. Weissmann N, Voswinckel R, Hardebusch T, Rosseau S, Ghofrani HA, Schermuly R, Seeger W and Grimminger F (1999) Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. Am J Physiol 276:L90-L95.
39. 2+/calmodulin-dependent protein kinase II. J Neurochem 56:294-298.
40. Yingling JD, Fuller LZ and Jackson BA (1994) Modulation of cyclic AMP metabolism by protein kinase C in PC18 cells. Neurosci Lett 166:157-160.
41. Yu H, Cai JJ and Lee HC (1996) Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts. Mol Pharmacol 50:549-555.
42. 2+ pathway in the cardiac κ-opioid receptor. Am J Physiol 274:C82-C87.
43. Zhu SJ, Kavanaugh MP, Sonders MS, Amara SG and Zahniser NR (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J Pharmacol Exp Ther 282:1358-1365.